![](https://vistapglobal.com/wp-content/uploads/2021/01/pexels-anna-shvets-3845625.jpg)
Reportedly, Optum, a diversified health services company and part of UnitedHealth Group (UNH), and Change Healthcare, a health care technology leader have agreed to come together to improve and upgrade healthcare services for everyone. Change Healthcare will join with OptumInsight to provide technology-enabled services and research, software, and data analytics, and advisory and revenue cycle management for a combined mission to make healthcare work quicker and better at low cost. Upon closure, Neil de Crescenzo, President, and CEO of Change Healthcare will serve as OptumInsight’s chief executive officer, leading the combined organization. The deal is expected to close second-half of 2021 and includes the acquisition of Change Healthcare’s common stock for $25.75 per share in cash. The transaction is subject to Change Healthcare shareholders’ approval, and other customary and regulatory approvals. Also, Private equity funds affiliated with The Blackstone Group, in ownership of approximately 20% of the common stock of Change Healthcare, have agreed to vote the shares they control in favor of the combination.
Change Healthcare offers key technologies with advanced clinical decision, administrative and financial support capabilities, resulting in better workflow, better transactional connectivity across the health care system. Optum offers comprehensive clinical expertise, modern analytics along with innovative technologies, and extensive experience targeted to improve clinical and health experience for all.
“Together we will help streamline and inform the vital clinical, administrative, and payment processes on which health care providers and payers depend to serve patients,” “We’re thrilled to welcome Change Healthcare’s highly skilled team to create a better future for health care.” stated Andrew Witty, President of UnitedHealth Group and CEO of Optum.
The combined vision to include:
- The combined company will help clinicians make the most informed and clinically advanced patient care decisions, more quickly and easily with Change Healthcare’s technology for integrating evidence-based clinical criteria directly into the clinician’s workflow along with Optum’s clinical analytics expertise ensuring appropriate sites of care and consistent best health, quality and cost outcomes.
- It will reduce significant levels of administrative waste, enabling more informed and accurate services and processing.
- Change Healthcare’s payment capacities along with Optum’s highly automated payment network will simplify financial interactions among care providers, payers, and consumers and accelerate faster, real-time payment, ensuring the physicians get paid more quickly, accurately, and reliably.
Howard Lance, Chairman of the Board of Directors of Change Healthcare stated, “Change Healthcare has made significant progress executing its strategic objectives, including advancing innovation, accelerating growth, and improving the effectiveness of the U.S. health system. We are delighted to have in Optum a partner that shares a common vision of creating a better future for health care for the people and communities we serve and see this combination as in the best interests of all of our stakeholders.”
Dow 30 component UnitedHealth Group Incorporated (UNH) operates as a diversified health and well-being company in the United States. The company’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. To learn more about (UNH) please visit the Vista Partners Company Dedicated UNH Coverage Page.
If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive! Please join us at Vista Partners and receive our FREE email updates throughout the week and view our exclusive content and research.